The current guidelines following an acute coronary syndrome recommend dualantiplatelet therapy (DAPT) (aspirin plus a P2Y 12 antagonist) alongside lifestyle modifications, including more regular physical activity. It is currently unknown whether regular exercise affects the pharmacology of DAPT. Aim: To explore how exercise-induced improvements in vascular and platelet function affect the efficacy of DAPT, in a cross-sectional study of men with different physical activity levels (training status). Methods: A total of 42 healthy, normal-weight, middle-aged men were divided into 3 groups: untrained, moderately trained and well-trained. Their platelet reactivity (agonist-induced % aggregation) was investigated in platelet-rich plasma at rest and after inhibition with aspirin and ticagrelor and/or prostacyclin and nitric oxide added to the blood in vitro, and after physiological tests of vascular function; passive movement of the leg, flow-mediated dilation and one-leg knee-extensor exercise. Vascular function of the femoral artery (changes in arterial blood flow) was assessed by ultrasound Doppler. Results: Platelets from the well-trained subjects had lower basal reactivity, a higher sensitivity to the anti-aggregatory effects of prostacyclin and were more potently inhibited by DAPT compared to the untrained subjects. The moderately trained and well-trained subjects had a superior vascular function compared to untrained subjects, and their platelets were more inhibited by the passive movement, flow-mediated dilation and one-leg knee-extensor exercise. Discussion: A habitually active lifestyle leads to an increased platelet sensitivity to pharmacological and physiological platelet inhibitors. We suggest that physical activity habits (training status) should be considered when personalizing and optimizing antithrombotic treatment strategies.
| INTRODUCTION
The current guidelines after an acute coronary syndrome (ACS) include dual-antiplatelet therapy (DAPT) for at least 12 months, alongside recommendations of more regular aerobic physical activity. 1 DAPT consists of aspirin, inhibiting platelet thromboxane A 2 (TXA 2 ) production, and a P2Y 12 receptor antagonist, inhibiting the platelet adenosine 5 0 -diphosphate (ADP) receptor (P2Y 12 ). 2 Some patients have high on-treatment platelet reactivity despite receiving DAPT, and this is associated with a higher risk of recurrent thrombotic events. 3 Hence, more optimized treatment strategies are warranted to prevent the high mortality and morbidity of ACS.
We have previously suggested that the efficacy of P2Y 12 inhibitors may vary markedly in individuals dependent on their vascular function as P2Y 12 inhibitors dramatically increase the antiplatelet effects of both prostacyclin and nitric oxide. [4] [5] [6] Potentiating the inhibitory actions of these endothelial-derived mediators may be a central mechanism through which P2Y 12 inhibitors exert their antithrombotic protection in vivo.
As regular physical activity improves endothelial function 7, 8 and enhances platelet sensitivity to prostacyclin, 9 the efficacy of antiplatelet drugs, in particular P2Y 12 inhibitors, may also be affected by an individual's habitual physical activity level. Insight into how regular physical activity influences antiplatelet drug efficacy is important for the assessment of whether the habitual physical activity level of an individual should be taken into account when prescribing antiplatelet drugs.
We hypothesized that regular physical activity is associated with a high level of vascular endothelial function in parallel with a lower basal platelet reactivity and higher platelet sensitivity to DAPT and prostacyclin.
To test this hypothesis, we investigated platelet and vascular function in healthy middle-aged men with different training statuses and tested their platelet responses to pharmacological inhibition with DAPT and their sensitivity to the endogenous physiological platelet inhibitors prostacyclin and nitric oxide.
| RESULTS

| Subject characteristics
A total of 42 male middle-aged healthy subjects with a mean age of 52 AE 1 years participated in the study. They were divided into 3 groups: untrained (n = 13), moderately trained (n = 15) and well-trained (n = 14), based on their self-reported IPAQ score and the results of their VO 2max test, and there was no difference in age between the groups (Table 1 ). The untrained subjects had not participated in regular physical activity for the past 9 AE 2 years whereas the moderately trained and well-trained subjects had had an active lifestyle for the past 28 AE 2 and 26 AE 2 years respectively. Correspondingly, the moderately trained and well-trained subjects reported in the IPAQ that they participated in more hours of moderate and intense exercise per week (Table 1 ), and their cardiorespiratory fitness level (peak VO 2 max at exhaustion) was higher than the untrained subjects ( Table 1 ). The well-trained subjects scored higher on all these parameters than the moderately trained subjects. Resting heart rate was lower in the welltrained subjects compared to the untrained subjects ( Table 1 ). The moderately trained and well-trained subjects had a larger femoral artery diameter compared to the untrained subjects (Table 1) . There was no difference in glycated haemoglobin (haemoglobin A1c) or fasting glucose levels between the groups, but the fasting insulin levels and the homoeostatic model assessment of insulin resistance (HOMA IR ) were lower in the moderately and well-trained subjects ( Table 1) .
The international normalized ratio (INR) prothrombin time test was longer in the moderately and well-trained subjects, and these 2 groups also had lower levels of factors II, VII and X compared to the untrained group (Table 1) .
| Basal platelet reactivity
When platelet-rich plasma (PRP) obtained from blood drawn at rest was stimulated with the platelet agonists collagen or adrenaline, the aggregation curves from the platelets from the well-trained subjects were lower than the curves from the untrained and moderately trained subjects, indicating that platelets from the well-trained subjects required more agonist stimulation to aggregate indicating that they had lower basal platelet reactivity compared to the untrained and moderately trained subjects (Figure 1 ). Basal platelet reactivity to arachidonic acid (AA), ADP, thrombin receptor-activating peptide (TRAP6) and the TXA 2 mimetic U46619 was, however, not different between the groups ( Figure S1 ).
| Platelet sensitivity to pharmacological inhibition by DAPT
Platelet aggregation was potently inhibited by DAPT (1 lmol/L ticagrelor and 100 lmol/L aspirin), (Figure 2 and Figure S2 ). Collagen, adrenaline and U46619-induced platelet aggregation was more potently inhibited by DAPT in the well-trained subjects compared to the untrained and moderately trained subjects (Figure 2A-E) . The inhibitory effect by aspirin (100 lmol/L) was similar amongst the subjects ( Figure S3 ), whilst ticagrelor on its own inhibited AA-induced platelet aggregation potently in the moderately and well-trained subjects compared to the untrained subjects where there was~20% residual aggregation not inhibited by ticagrelor ( Figure 2F and Figure S4A ).
| Platelet prostacyclin sensitivity and response to DAPT in the presence of prostacyclin
Platelets from the well-trained subjects were more sensitive to the inhibitory effects of prostacyclin compared to the 2 other groups (Figure 3 ). The concentration of prostacyclin, required to inhibit 10 lmol/L TRAP6-induced platelet aggregation by 50% (IC 50 ), was lower in the well-trained subjects (mean, 95% confidence interval) (15 nmol/L, 12-19) compared to the untrained subjects (32 nmol/L, 28-37). Adding adrenaline (10 lmol/L), in combination with TRAP6 (10 lmol/L), diminished the inhibitory potency of prostacyclin in all groups (Figure 3D ). In combination with DAPT, platelet sensitivity to prostacyclin was strongly enhanced in all subjects, but most potently so in the well-trained subjects: (IC 50 2 nmol/L, 2-3) vs (4 nmol/L, 4-5) in the untrained subjects ( Figure 3 ). There was a concentration-dependent inhibitory effect on platelet aggregation by the DEA/NONOate, which was further potentiated by DAPT, but there was no difference in responses between the different groups ( Figure S5 ). Femoral arterial blood flow was higher in the well-trained subjects at rest, and 3 minutes of passive leg movement led to a higher increase in femoral arterial blood flow in the moderately and well-trained subjects compared to the untrained subjects ( Figure 4A ). There was a moderate positive correlation (r = .41) between the increase in femoral arterial blood flow following the passive movement and the subjects' VO 2max ( Figure 4B ). There was right-hand shift in the ADP-induced platelet aggregation curves (indicating inhibition of platelet reactivity) following the passive movement that became increasingly separated and shifted to the right with increasing training status ( Figure 4C -E).
| Flow-mediated dilation
There was a significant increase in femoral arterial diameter in all the groups after the flow-mediated dilation (FMD), and the largest increase was seen in the well-trained group.
( Figure 5A ). There was a positive correlation (r = .55) between the FMD response (% difference between the diameter of the femoral artery at rest and the peak diameter of the femoral artery after the FMD) and the passive movement response ( Figure 5B ). The FMD test did not affect collagen-induced platelet reactivity in the untrained subjects ( Figure 5C ), but there was an inhibitory effect (separation of the curves) in the moderately trained subjects (Figure 5D ) and a clear inhibitory effect on platelet reactivity in the well-trained subjects where there was a reduction in maximum platelet aggregation to collagen after the FMD ( Figure 5E ). A similar pattern was seen for ADP and TRAP-6-induced aggregation ( Figure S6 ). Plasma levels of the prostacyclin breakdown product (6-keto PGF 1ɑ ) did not differ between the groups at baseline and were not altered by the FMD (Table 1 ).
| One-leg knee-extensor exercise
Femoral arterial blood flow increased to a similar level in the 3 groups (~3000 mL/min) following the set load (12 W) (low to moderate intensity) one-leg knee-extension exercise ( Figure 6A ). Adrenaline-induced platelet aggregation was unaffected in the untrained subjects ( Figure 6B ), but was progressively inhibited in the moderately trained ( Figure 6C ) and the well-trained subjects ( Figure 6D ). There was a higher increase in femoral arterial blood flow following the relative load (40% of max.) in the moderately and well-trained subjects compared to the untrained subjects ( Figure 7A ), reflected by their higher workload (17 AE 2 W in the untrained vs 23 AE 2 W in the moderately trained vs 32 AE 1 W in the well-trained subjects). The 40% max workload increased platelet reactivity to adrenaline in the untrained subjects, shifting the concentration-response curve to the left ( Figure 7B ), whereas platelet reactivity in the other 2 groups was not affected (Figure 7C, D) . Plasma levels of 6-keto PGF 1ɑ did not change after the 40% exercise compared to baseline (Table 1) .
Basal platelet reactivity (agonist-induced % platelet aggregation) to 6 concentrations of the platelet agonists (A) collagen and (B)
adrenaline. Platelet-rich plasma from venous blood drawn at rest from the antecubital vein of untrained (n = 13), moderately trained (n = 15) and well-trained (n = 14) middle-aged men. ɸ P < .05: The platelet aggregation curve from the well-trained subjects was lower than the curves from the untrained and moderately trained subjects (indicating lower basal platelet reactivity)
White blood cells (WBC) count, mean platelet volume (MPV) and percentage of large platelets (P-LCR) increased in the blood samples from all subjects after both the 12 W and 40% one-leg knee exercise ( Figures S7 and S8 ). Platelet count, however, only increased in the untrained and moderately trained subjects after the exercise (Figures S7B and S8B).
| DISCUSSION
The main findings of the current study were as follows: (i) basal platelet reactivity to collagen and adrenaline was lower in well-trained subjects compared to anthropometrically matched, moderately trained or untrained middle-aged men.
(ii) Platelets from the well-trained subjects were more potently inhibited by DAPT ex vivo. (iii) Platelet sensitivity to the anti-aggregatory effects of prostacyclin was also higher in the well-trained subjects. (iv) Active one-leg knee-extension exercise, passive movement and FMD had a greater inhibitory effect on platelets from the moderately trained and well-trained subjects compared to the untrained subjects.
The subjects included in the 3 study groups were selected to be healthy, non-smokers, and of similar age, and their body composition (BMI and waist circumference), cholesterol levels and fasting levels of plasma insulin/glucose were below the WHO definition of the levels considered as cardiovascular risk factors. 10 Thus, with regard to cardiovascular risk factors, the 3 groups differed significantly from each other only in terms of habitual physical activity level. To our knowledge, this is the first study to investigate basal platelet reactivity in healthy middle-aged men with different training status. The lower basal platelet reactivity observed in the well-trained subjects is in line with results from previous cross-sectional studies performed in younger male 11 and female subjects. 12 Using the same optimul platelet aggregation assay as in the current
The anti-aggregatory effects of dual-antiplatelet therapy (DAPT) in platelet-rich plasma (PRP) from untrained (n = 13), moderately trained (n = 15) and well-trained (n = 13-14) subjects were pre-incubated for 30 minutes with DAPT consisting of the P2Y 12 inhibitor ticagrelor (1 lmol/L) and the cyclooxygenase inhibitor aspirin (100 lmol/ L) or vehicle (0.5% DMSO + 0.03% EtOH in phosphate buffer saline) before inducing platelet aggregation by (A) collagen (full concentration-response curve), (B) 10 lg/ mL collagen, (C) adrenaline (full concentration-response curve), (D) 10 lmol/L adrenaline or (E) the thromboxane A 2 mimetic U46619 and (F) % platelet aggregation in response to 0.6 mmol/L arachidonic acid (AA) in PRP treated only with ticagrelor. *P < .05 welltrained or moderately trained compared to untrained subjects and # well-trained compared to moderately trained subjects study, we have previously reported that a 3-month exercise intervention lowered basal platelet reactivity to collagen in premenopausal women of a similar age to the men in the current study. 9 Taken together, these studies show that habitual physical activity modulates platelet function at rest, lowering the reactivity threshold of platelets.
In agreement with our hypothesis, platelets from the well-trained subjects were more potently inhibited by DAPT compared to the untrained subjects. Platelets from moderately trained subjects were also more strongly inhibited by the P2Y 12 inhibitor ticagrelor compared to the untrained subjects. In order to mimic the physiological environment where these drugs normally act, where the endogenous platelet regulator prostacyclin is continuously released from the vascular endothelium, we added low (nmol/L) concentrations of prostacyclin to the assay and found that the inhibitory potency of DAPT was further enhanced, mostly so in the well-trained subjects. We have previously suggested that potentiating the inhibitory actions of prostacyclin may be a central mechanism through which P2Y 12 inhibitors exert their antithrombotic protection in vivo. 4, 5 The results from the current study suggest that the habitual physical activity levels of individuals may need to be considered in the optimization of their antithrombotic treatment strategies. Accordingly, ACS patients with a history of a physically active lifestyle may have a different baseline platelet reactivity and DAPT efficacy compared to sedentary patients and may therefore need less medication, for instance monotherapy with a P2Y 12 antagonist. 13 Conversely, stronger antiplatelet medication regimens may be warranted in patients with a sedentary lifestyle. These findings may also serve as a motivator to sedentary patients, highlighting previously unknown benefits to regular physical activity-increasing the efficacy of their DAPT medication and potentially the level of antithrombotic protection. We found that platelets from the well-trained subjects were more sensitive to the anti-aggregatory effects of prostacyclin but not to nitric oxide. This finding is in agreement with our previous results from a longitudinal intervention study in middle-aged women showing increased platelet sensitivity to arterially infused prostacyclin after training, without a change in the sensitivity to nitric oxide. 9 Combined, these data suggest that exercise training seems to particularly affect the platelet prostacyclin signalling pathway.
As the vascular endothelium plays a key role in regulating platelet reactivity in vivo, we wanted to see whether the lower basal reactivity in the well-trained men was associated with a superior vascular function. It is well known that regular physical activity leads to structural and functional improvements both at the macrovascular and at the microvascular levels. 14 We therefore assessed vascular function by 3 different (shear stress-induced nitric oxide-F I G U R E 3 Platelet sensitivity to the anti-aggregatory effects of prostacyclin, with or without dual-antiplatelet therapy (DAPT). Platelet-rich plasma (PRP) from untrained (n = 13), moderately (mod.) trained (n = 15) and well-trained (n = 14) middle-aged men was pre-incubated with vehicle (0.5% DMSO + 0.03% EtOH in phosphate buffer saline) or DAPT (1 lmol/ L ticagrelor and 100 lmol/L aspirin) for 30 minutes, followed by 1 minute prostacyclin, before the PRP was added to 96-well plates pre-coated with the platelet agonists: (A) 20 lmol/L adenosine diphosphate (ADP); (B) 10 lmol/L the TXA 2 mimetic U46619; (C) 10 lmol/L thrombin receptor-activating peptide 6 (TRAP-6); or (D) 10 lmol/L TRAP-6 + 10 lmol/L adrenaline to induce platelet aggregation. P < .05 well-trained compared to (*) untrained and (#) moderately trained subjects dependent) physiological tests: passive leg movement, FMD and one-leg knee-extension exercise. We also wanted to see whether we could capture any anti-aggregatory effects on the platelets by these physiological interventions, to see whether the interactions between the blood vessels and blood platelets differed with training status. Using the passive movement test, 15 we were able to show that vascular function in the moderately trained and the well-trained subjects was superior compared to the untrained subjects. We also made the novel observation that the passive movement had a larger inhibitory effect on platelet aggregation in the moderately trained and well-trained subjects, indicating that they had a higher bioavailability of shear stress-induced endothelial-derived platelet inhibitors (presumably nitric oxide) following this physiological challenge. The subjects that had the largest increase in femoral arterial blood flow following the passive leg movement also had the highest FMD response. We also show for the first time that FMD inhibits platelet aggregation in a training status-dependent way, having the strongest inhibitory effect on platelets from well-trained subjects. Acute exercise has been shown to affect platelet function in an intensity-dependent manner where moderate exercise tends to suppress platelet reactivity whereas strenuous exercise has been shown to temporarily increase platelet reactivity. 16, 17 In the current study, we used a localized model of exercise involving a single active muscle group in the leg. 18 We selected this model as we wanted to investigate platelet responses to acute exercise in a setting with lower levels of catecholamine release compared to full body exercise. 19 We found that 12 W had an inhibitory effect on platelet reactivity in the moderately and well-trained subjects only, despite increasing the MPV and percentage of large platelets in the blood samples. Large platelets are typically considered to be more reactive to aggregate, 20 but in the current study, this was not the case in the moderately and well-trained subjects, as their platelet reactivity was lower after exercise, indicating that the exercise triggered an inhibitory milieu strong enough to also inhibit these larger platelets. Increasing the workload to 40% relative load triggered a hyperaggregation response of the platelets in the untrained subjects only and removed the inhibitory effect of the lower intensity exercise in the trained subjects. Hence, exercise at lower (moderate) intensities may be more favourable when it comes to acute modifications of platelet reactivity. Overall, the hyperaggregatory response to acute exercise in the untrained subjects highlights the importance of caution when introducing high-intensity exercise to sedentary middle-aged male subjects.
| Study limitations
A limitation of this cross-sectional study is that the favourable antithrombotic effects in the well-trained subjects could in part be due to genetic selection or differences in characteristics other than training status between groups. Future studies should follow up on our findings and assess the longitudinal effects of physical activity on platelet function. As this study population was limited to healthy middle-aged men, further F I G U R E 4 A, Femoral arterial blood flow at rest and after 3 minutes of passive one-legged knee-extension movement in untrained (n = 12), moderately trained (n = 15) and well-trained (n = 14) middleaged men. B, Correlation between the change in femoral arterial blood flow following the passive movement and cardiorespiratory fitness level (VO 2 max, mL/min/kg). Platelet reactivity (% platelet aggregation induced by adenosine diphosphate, ADP) at rest and after the passive movement in platelet-rich plasma obtained from (C) untrained (n = 10), (D) moderately trained (n = 15) and (E) welltrained (n = 14) subjects. ¤ P < .05: compared to baseline and *P < .05: compared to the untrained subjects LUNDBERG SLINGSBY ET AL.
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research is needed to determine the effects of training on platelet activity and sensitivity to DAPT in people with other risk factors for cardiovascular diseases and/or in patients with ACS. Another limitation with this study was that the DAPT was added to the blood in vitro rather than dosed in vivo, which may yield different results due to differences in pharmacokinetics and acute effects of DAPT in vivo vs in vitro.
The investigators performing the platelet aggregation assay were not blinded to the identity of the blood samples, but the potential for bias was minimal as this is a quantitative test of platelet aggregation. The investigator analysing the FMD files was, however, blinded to the training status of the individuals as the potential for bias was higher in this analysis.
(FMD) response (change in femoral artery diameter from rest to peak during 5-minute deflation of occlusion cuff around the thigh) in untrained (n = 7), moderately trained (n = 8) and well-trained (n = 9) middle-aged men. B, Correlation between the femoral arterial response to passive movement (blood flow mL/min) and response to FMD (% change in femoral arterial diameter). Platelet reactivity (collagen-induced % platelet aggregation) at baseline and immediately after opening the 5-minute occlusion (FMD test) in plateletrich plasma obtained from (C) untrained (n = 12), (D) moderately trained (n = 15) and (E) well-trained (n = 12) subjects. ɸ P < .05 curve is lower than baseline. ¤ P < .05, ¤¤ P < .005 and ¤¤¤ P < .0005 compared to resting baseline F I G U R E 6 A, Femoral arterial blood flow at rest and after 10 minutes of acute dynamic one-leg knee-extension exercise at a set workload (12 Watt, W). Adrenalineinduced platelet aggregation in platelet-rich plasma from (B) untrained (n = 12), (C) moderately trained (n = 15) and (D) welltrained (n = 12) middle-aged men, before and after the 12-W acute one-leg kneeextension exercise. ¤ P < .05: compared to baseline and ɸ P < .05 curve is lower than baseline. *P < .05: compared to untrained subjects
| CONCLUSIONS
We have shown that middle-aged men with a physically active lifestyle have platelets that are more easily inhibited by pharmacological platelet antagonists (DAPT) and have a higher sensitivity to the physiological platelet inhibitor prostacyclin, allowing for a more responsive communication between their blood vessels and blood. Conversely, it can be argued that healthy and normal-weight middle-aged men with a sedentary lifestyle have platelets that require more prostacyclin and DAPT to be inhibited and have a hyperactive response to acute exercise. Overall, this study clearly demonstrates that regular physical activity has a beneficial impact on platelet function and that DAPT is most efficacious at inhibiting platelet aggregation in healthy middleaged men with a physically active lifestyle. These results indicate that training status may need to be considered when personalizing and optimizing antithrombotic treatment strategies in patients receiving DAPT. Future studies should investigate whether a longitudinal exercise training intervention in previously sedentary patients with ACS can improve the efficacy of their DAPT treatment.
| MATERIALS AND METHODS
The study protocol was approved by the ethics committee of Copenhagen (H-2-2014-112). All subjects were recruited after providing their written informed consent in accordance with the Declaration of Helsinki. The material submitted in this paper conforms with Good Publishing Practice in Physiology. 21 
| Recruitment of subjects
The subjects were recruited via newspaper advertisements where the inclusion criteria were as follows: healthy middle-aged men, 45-60 years old, normal weight (BMI >18.5 and <27 kg/m 2 ), normotensive (blood pressure <140/ 90 mm Hg) and normal waistline (<94 cm). The waistline criteria were strictly adhered to as central obesity has been associated with a reduced sensitivity to prostacyclin and nitric oxide. 22 Exclusion criteria were as follows: smoking (the past 15 years), excessive alcohol intake (>14 units/ wk), regular medication intake and blood donation <4 months before participating in study. Training status was defined as untrained (no regular physical activity in the past 2 years or more), moderately trained (2-3 hours of moderate regular physical activity per week, for the past 15-20 years or more) and well-trained (>4 hours of moderate-to-intense regular physical activity per week, for the past 15-20 years or more).
| Study design
The study consisted of a health screening day and 2 experimental days: a platelet function testing day and a vascular function testing day.
| Health screening day
All participants underwent a health examination, including a 10-point resting electrocardiogram (ECG), to confirm that the subjects were healthy and that the inclusion criteria were met. A blood test was taken to ensure that F I G U R E 7 A, Femoral arterial blood flow at rest and after 10 minutes of acute dynamic one-leg knee-extension exercise at a relative workload: 40% of the maximum ability (determined in a max test performed on the health screening day), corresponding to 17 AE 2 Watt (W) for the untrained, 23 AE 2 W for the moderately trained and 32 AE 1 W for the well-trained subjects. Adrenaline-induced platelet aggregation in platelet-rich plasma from (B) untrained (n = 12), (C) moderately trained (n = 15) and (D) well-trained (n = 12) subjects, before and after the 40%. max acute exercise.
¤ P < .05: compared to baseline. *P < .05 compared to untrained subjects. ɸ P < .05 curve is higher than baseline.
LUNDBERG SLINGSBY ET AL. haematological markers, cholesterol levels and coagulation factors were within normal range (analysed within 2 hours at Rigshospitalet in Copenhagen, Denmark). The subjects then performed a one-leg knee-extension exercise incremental max test to determine the watt (W) representing 40% of their maximum (ahead of the vascular function testing day). Each subject completed the short version of the International Physical Activity Questionnaire (IPAQ) to quantify their self-reported physical activity habits. 23 To objectively characterize fitness level, their pulmonary maximal oxygen uptake (VO 2max , Oxycon Pro, Intramedic) was assessed in an incremental bicycle ergometer exercise test until exhaustion (respiratory exchange ratio >1.1).
| Experimental days-platelet function testing day and vascular function testing day
The subjects were advised to avoid non-steroidal antiinflammatory drugs for at least 2 weeks and not to perform exercise within 48 hours of the experimental days (to avoid confounding effects of acute exercise). In preparation for each experimental day, the subjects had fasted overnight.
| Platelet function testing day
The primary outcomes of this day were as follows: (i) investigate the anti-aggregatory responses to pharmacological inhibition with DAPT and (ii) examine whether platelet prostacyclin and nitric oxide sensitivity differs with training status. To this end, blood was drawn from the antecubital vein (after a 10-minute rest in a supine position), into 3.2% citrate monovettes (s-monovette, Sarstedt). The blood was immediately analysed for platelet count, MPV, large platelet ratio (P-LCR; >12 fL and <30 fL), haemoglobin, haematocrit and WBC using a haematology analyser (XP-300, Sysmex). Blood samples were then centrifuged (5804 R, Eppendorf) at 180 9 g for 10 minutes at 20°C, to obtain PRP. Remaining blood was centrifuged further at 15 000 9 g for 2 minutes to obtain platelet-poor plasma (PPP). The PRP was then treated with either (i) the reversible purinergic P2Y 12 . The plates were placed on a shaker (BioShake iQ; Q Instruments) at 37°C to mix at 1200 rpm for 5 minutes. Absorbance was measured at 595 nm (Emax Precision Microplate Reader, Molecular Devices) and % platelet aggregation calculated. [24] [25] [26] All assays were completed within 2.5 hours of drawing the blood.
| Vascular function testing day
The primary outcomes with this day were to (i) test whether the trained subjects had lower basal reactivity than then untrained subjects. Basal platelet reactivity was defined as agonist-induced platelet aggregation in PRP obtained from blood drawn at baseline (after 30-minute rest); (ii) evaluate the subject's vascular function; and (iii) platelet aggregation responses to physiological tests (to examine the interactions between platelet function and vascular function). An intravenous catheter (Vasofix Safety, 19G; B. Braun) was placed in the antecubital vein, followed by 30-minute rest in an upright seated position before blood was drawn to test basal platelet reactivity. Blood samples drawn into 3.2% citrate monovette containers and were immediately centrifuged to obtain PRP which was processed as outlined in experimental day 1 (minus the DAPT/prostacyclin or nitric oxide incubations) and plated out on pre-prepared optimul 96-well plates testing ADP, collagen, adrenaline, TRAP6 and U46619-induced platelet aggregation at full concentration-response curves. The assay took about 25 minutes from blood drawn to plate read. The subjects then commenced the passive movement test 15 by passively relaxing all the muscles in the right leg, whilst the lower part of the right leg was strapped to an ergometer and moved by one of the investigators at 60 rpm frequency for 3 minutes. Femoral arterial blood flow was measured at baseline and after the passive movement with ultrasound Doppler (Vivid E9, GE Healthcare) equipped with a linear probe (L5) operating at an imaging frequency of 4/8 MHz and a Doppler frequency of 4.2 MHz. The site of blood velocity measurements in the common femoral artery was distal to the inguinal ligament but above the bifurcation into the superficial and profound femoral branch to avoid turbulence from the bifurcation. All recordings were obtained at the lowest possible insonation angle (always <60 degrees). The sample volume was maximized by choosing the widest section of the vessel, and the measurements were made without interference of the vessel walls. A low-velocity filter (velocities <1.8 m/s) rejected noise caused by turbulence at the vascular wall. Doppler tracings and B-mode images were recorded continuously, and Doppler tracings were averaged over 45 seconds. After a 15-minute rest in a supine position, the FMD test 27 was initiated, by rapidly inflating a cuff (E20, Hokanson) around the subject's thigh, holding the pressure at 240 mg Hg for 5 minutes, followed by rapid deflation. A recording of superficial femoral arterial blood flow was preformed 30 seconds before cuff deflation and in the following 5 minutes. The response to the FMD test was calculated by comparing the diameter of the femoral artery at rest to the diameter at the peak dilation of the artery following the opening of the cuff. Blood samples for platelet function testing were drawn from the arm at baseline and immediately after opening the cuff. After a 15-minute rest in a seated position, the one-leg knee exercise protocol started with the subject's right leg being strapped into the ergometer and subjects were instructed to actively kick forward and passively return their leg at a kicking frequency of 60 rpm. The workload was set to 12 W (representing low to moderate intensity). Blood samples and femoral blood flow measures were obtained at baseline and after 10 minutes. The workload was then increased to 40% of the subjects' personal maximum, and blood samples and femoral arterial blood flow measures were captured after 10 minutes. Blood samples for prostacyclin PGF 1ɑ were drawn at baseline, after the FMD and after the 40% one-leg exercise into EDTA Vacutainers and placed on ice until they were centrifuged at 1000 9 g 15 minutes, 4°C, plasma was pipetted off and stored at À80°C until analysis using an immunoassay kit (EIA; 515211, Cayman Chemical Co).
| Statistical analysis
Power calculations of the primary outcome measure (platelet function and vascular function) were made to determine the study size, using the standardized difference method 28 where the ɑ-level was set to 0.05 and the power level to 0.8. The effect size was set to detect a 50% difference in femoral blood flow following the passive movement and a 50% increased platelet sensitivity to the inhibitory effects of prostacyclin, based on previous reports. 9, 22 Data are reported as mean AE standard error of mean (SEM). Statistical analyses were performed using GraphPad Prism5 and groups were compared using one-way or two-way ANOVA as appropriate, with Bonferroni multiple comparison posttest. Differences in platelet count, WBC, MPV and % large platelets from baseline to one-leg exercise were detected using a paired two-tailed t test. The Kolmogorov-Smirnov test and the Shapiro-Wilk test of normality confirmed that the data were normally distributed. Final number of replicates are indicated in each figure legend.
